Jones Evan/ Fa Buys Shares of Veracyte, Inc. $VCYT
Key Points
- Jones Evan/ Fa bought 5,272 shares of Veracyte, Inc. ($VCYT).
- $VCYT last traded around $47.33.
Jones Evan/ Fa, insider at Veracyte, Inc. ($VCYT), bought 5,272 shares at an average price of $0.00. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.
Veracyte, Inc. ($VCYT) Stock
Veracyte, Inc. Earnings
Analysts Set New Price Targets
About Veracyte, Inc.
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.